Concord Drugs Limited Share Price

₹ 65.60

+₹2.05 (3.23%)
1D
Last updated 02 Nov, 2026, 15:11 IST
BSE: 538965
|
Pharmaceuticals

Concord Drugs Limited Share Price Today

As of 2 Nov 2026, Concord Drugs Limited share price is ₹65.60. The stock opened at ₹67.94, compared to its previous close of ₹63.55. During today's trading session, Concord Drugs Limited share price moved in the range of ₹65.00 to ₹67.94, with an average price of ₹66.47 for the day. Looking at its last 52-week, the stock has touched a low of ₹59.99 and a high of ₹92.52.

Share price over the last 1 day fell from 67.88 to 65.60, ranging between 65.00 and 67.88.
₹65.00
3.23% up today
₹67.94
1D LOW
1D HIGH

Concord Drugs Limited Stock Insights

Latest Earning
Op Profit TrendUp by 105.33% QoQ
Latest Earning
Net Profit TrendUp by 109.43% QoQ
Latest Earning
Revenue TrendUp by 74.04% YoY
Stock Performance
OutperformingBeat Nifty by 5.36 % in last 1 year
Concord Drugs Limited stock performance
Open₹67.94
High₹67.94
Low₹65.00
Prev. close₹63.55
Concord Drugs Limited trading activity
Volume2,810
Average traded price₹66.36
Last traded time03:11:57 02 Nov
Last traded quantity143
Circuit
L
H
₹50.84
₹76.26
52-week
L
H
₹59.99
₹92.52
Mkt Cap Cr
83.73
P/E
40.74
P/B
1.79
ROA
2.74%
ROE
2.17%
ROCE
5.12%
Quick Ratio
1.32
EV/EBITDA
16.72

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Concord Drugs has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Concord Drugs appears overvalued compared to its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
Concord Drugs revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,76,306.2184.09.64.7%11.42%11.37%0.7533.6
Laurus Labs1,29,242.6897.021.3311.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Concord Drugs Limited Company Background

ISIN
INE858L01010
Sector Market Cap
₹ 83.73 Cr

Concord Drugs Limited is an India-based pharmaceutical company. The Company's principal activity is to manufacture licensed drugs based on the formulations approved. The Company is focused on developing drug delivery systems, including multiple unit pellet system (MUPS), sustained release, and modified release pellets. It operates a Current Good Manufacturing Practice (cGMP) contract manufacturing formulation-fill-finish facility, offering a full spectrum of pharmaceutical development and manufacturing services for drug products. The Company's products include pharmaceutical ready to fill pellets, MUPS; tissue bio adhesive; injectables (small volume parenterals); oral solid dosages (tablets); oral solid dosages (capsules); liquid orals, and dry syrup (powder). It also offers hand sanitizers under the brand name, PROTON SAFE. It manufactures hand sanitizers on third party basis also. The Company's oral liquid dosage forms include solutions, syrups, and suspensions.

Concord Drugs Limited Financial Highlights

  • Revenue: Concord Drugs Limited reported revenue of ₹78.77 crore in FY26 vs ₹45.26 crore in FY25. It showed an increase of 74.04% on a yearly basis.
  • Operating Profit: Concord Drugs Limited reported an operating profit of ₹1.47 crore in FY26 vs ₹0.69 crore in FY25. It showed an increase of 113.04% on a year-on-year basis.
  • Net Profit: Concord Drugs Limited reported a net profit of ₹1.06 crore in FY26 vs ₹0.34 crore in FY25. It showed an increase of 211.76% on a yearly basis.

Concord Drugs Limited Quarterly Result Highlights

  • Concord Drugs Limited reported revenue of ₹20.95 crore in Jun 2026, compared with ₹37.90 crore in Mar 2026, representing a decrease of 44.72% on a quarter-on-quarter (QoQ) basis.
  • Concord Drugs Limited reported an operating profit of ₹1.54 crore in Jun 2026, compared with ₹0.75 crore in Mar 2026, representing an increase of 105.33% on a quarter-on-quarter (QoQ) basis.
  • Concord Drugs Limited reported a profit of ₹1.11 crore in Jun 2026, compared with ₹0.53 crore in Mar 2026, reflecting an increase of 109.43% on a QoQ basis.
  • The earnings per share (EPS) of Concord Drugs Limited stood at ₹0.95 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
45.08%
FII
0.00%
Other DII
0.00%
Retail and other
54.92%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Sep 20260.00%

Concord Drugs Limited Investment Returns

1 day
+3.84%
1 week
+1.41%
1 month
-12.83%
1 year
-4.42%
3 years
+94.26%
5 years
+122.94%

Concord Drugs Limited Share Price History

Concord Drugs Limited share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
30 Oct 26
₹65.99 / ₹63.55
-3.70%
29 Oct 26
₹68.77 / ₹65.99
+3.09%
28 Oct 26
₹65.98 / ₹64.01
-0.03%
27 Oct 26
₹69.00 / ₹64.03
-1.60%
Show more

Concord Drugs Limited Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹78.74₹45.24₹44.92₹52.08
Other Income₹0.03₹0.01₹0.01₹0.01
Total Revenue₹78.77₹45.26₹44.93₹52.09
Total Expenses₹77.30₹44.57₹44.30₹50.84
Profit Before Tax₹1.47₹0.69₹0.63₹1.25
Tax₹0.42₹0.36₹0.16₹0.26
Profit After Tax₹1.06₹0.34₹0.47₹0.99
EPS - Basic₹0.95₹0.34₹0.47₹1.06
EPS - Diluted₹0.95₹0.34₹0.47₹1.06

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹1.47₹0.69₹0.63₹1.25
Income before WC changes₹4.52₹4.13₹4.04₹4.51
Change in Assets-₹9.81-₹5.50-₹1.10₹6.21
Change in Liabilities-₹0.04₹5.29-₹1.93-₹8.67
Change in WC-₹9.85-₹0.21-₹3.03-₹2.46
Cash flow from Operations-₹5.75₹3.72₹0.79₹1.66
Cash flow from Investing-₹1.13-₹2.32-₹1.01-₹2.27
Cash flow from Financing₹7.04-₹1.43₹0.28₹0.62
Total Cash Flow₹0.16-₹0.02₹0.07₹0.02
Cash (Start of the year)₹0.12₹0.15₹0.08₹0.06
Cash (End of the year)₹0.28₹0.12₹0.15₹0.08

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹21.58₹24.38₹21.29₹14.77
Current Assets₹53.31₹40.76₹37.52₹43.46
Total Assets₹74.89₹65.14₹58.81₹58.23
Current Liabilities₹21.07₹25.16₹21.00₹21.61
Net Current Asset₹32.24₹15.60₹16.51₹21.84
Non-Current Liabilities₹5.31₹5.87₹3.98₹4.91
Equity Capital₹48.51₹34.11₹33.82₹31.70
Total Equity & Liabilities₹74.89₹65.14₹58.81₹58.23

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹75.85₹36.93₹43.26₹51.31
Other Income₹0.03₹0.01₹0.01₹0.01
Total Revenue₹75.88₹36.95₹43.27₹51.32
Total Expenses₹74.43₹36.31₹42.71₹50.20
Profit Before Tax₹1.45₹0.64₹0.56₹1.13
Tax₹0.41₹0.35₹0.14₹0.23
Profit After Tax₹1.04₹0.30₹0.42₹0.89
EPS - Basic₹0.93₹0.30₹0.42₹0.96
EPS - Diluted₹0.93₹0.30₹0.42₹0.96

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹1.45₹0.64₹0.56₹1.13
Income before WC changes₹4.23₹3.76₹3.68₹4.28
Change in Assets-₹13.31-₹1.39₹0.08₹0.51
Change in Liabilities₹3.27-₹0.15-₹1.59-₹2.20
Change in WC-₹10.04-₹1.54-₹1.51-₹1.68
Cash flow from Operations-₹6.22₹2.04₹1.96₹2.24
Cash flow from Investing-₹1.13-₹2.32-₹1.21-₹2.27
Cash flow from Financing₹7.51₹0.26-₹0.69₹0.05
Total Cash Flow₹0.16-₹0.02₹0.06₹0.03
Cash (Start of the year)₹0.12₹0.14₹0.08₹0.04
Cash (End of the year)₹0.27₹0.12₹0.14₹0.08

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹22.38₹25.16₹22.01₹15.23
Current Assets₹49.47₹33.42₹34.28₹41.40
Total Assets₹71.85₹58.58₹56.30₹56.63
Current Liabilities₹18.02₹18.61₹19.11₹20.90
Net Current Asset₹31.45₹14.82₹15.18₹20.50
Non-Current Liabilities₹5.32₹5.86₹3.37₹4.03
Equity Capital₹48.51₹34.11₹33.82₹31.70
Total Equity & Liabilities₹71.85₹58.58₹56.30₹56.63
* All values are in INR Crore
Concord Drugs Limited market depth
Bid quantityBid priceAsk priceAsk quantity
0000
0000
0000
0000
0000
Total bid quantity0
Total ask quantity0
Concord Drugs Limited technical summary
Bearish indicators1
Neutral indicators5
Bullish indicators2
OverallSlightly Bullish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
33.88
Neutral
ATR (14)
5.05
Neutral
STOCH(9,6)
24.53
Neutral
STOCH RSI (14)
20.75
Bullish
ADX(9)
18.1
Bullish
UO(9)
37.88
Neutral
ROC(12)
-10.99
Bearish
WillR(14)
-75.47
Neutral
Period
Simple value
Exponential vaue
5D
64.53
64.97
10D
66.29
66.39
20D
69.39
68.85
50D
74.56
72.22
100D
74.18
74.24
Volume trend — traded volume by day
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct0L
26 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Concord Drugs Limited
Pharmaceuticals
Add Stock
Add Another

Concord Drugs Limited Returns Calculator

Top Gainers

ITI Share Price
₹259.14
+43.19 (+20%)
ENGINERSIN Share Price
₹289.65
+37.8 (+15.01%)
AFFLE Share Price
₹1506.50
+164.7 (+12.27%)
PRAJIND Share Price
₹271.13
+29.43 (+12.18%)
DIXON Share Price
₹12319.00
+1319 (+11.99%)
See more

Top Losers

INDIGOPNTS Share Price
₹870.00
-127.3 (-12.76%)
CLEAN Share Price
₹662.60
-53 (-7.41%)
ZEEL Share Price
₹61.58
-4.82 (-7.26%)
SYRMA Share Price
₹1512.00
-113.3 (-6.97%)
POLICYBZR Share Price
₹931.00
-69.1 (-6.91%)
See more

Concord Drugs Limited Share Price FAQs

Please be aware that Concord Drugs Limited stock prices are subject to continuous fluctuations due to various factors.